Excelerate Energy, Inc.
Excelerate Energy Reports Strong Third Quarter 2026 Results
Category
317 releases
Excelerate Energy Reports Strong Third Quarter 2026 Results
Phase 3 EMERGE registrational trial of claseprubart in gMG evaluating 300mg/2mL Q2W and 300mg/2mL Q4W on track, with top-line results expected in…
AMH Reports Third Quarter 2026 Financial and Operating Results
Carriage Services Announces Third Quarter 2026 Results, Updates 2026 Guidance
Three-Year Contract Delivers Largest Wage Increase in More Than 25 Years CITY OF INDUSTRY, Calif., Nov. 4, 2026 — 220 workers at Ecobat, represented…
Achieves 30% Revenue Growth Year-Over-Year
Proposed Sale to include VIVO and LockeT Cardiac Electrophysiology product lines Divestiture would Complete the Company's Planned Transition to…
Achieved record quarterly revenue of $38.2 million (+9% YoY) and Net income of $2.5 million
Revenue growth of 27% driven by strong performance in molecular profiling services, including approximately 61,500 clinical cases, consisting of over…
Raises FY 2026 Sales and Adjusted EPS Outlook on Continued Strong Demand Across Its Diversified End Markets
18% revenue growth, 11% organic revenue growth, and 32% adjusted EPS growth1